Tomoichi Shinohara

Novel Design of Nonpeptide AVP V₂Receptor Agonists:  Structural Requirements for an Agonist Having 1-(4-Aminobenzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepine as a Template

Kazumi Kondo, Hidenori Ogawa, Tomoichi Shinohara et al. · Journal of Medicinal Chemistry · 2000 · 62 citations · Full text

Po Administration, Novel Design, Pharmacotherapy +18

Characterization of Orally Active Nonpeptide Vasopressin V₂ Receptor Agonist. Synthesis and Biological Evaluation of Both the (5<i>R</i>)- and (5<i>S</i>)-Enantioisomers of 2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1<i>H</i>-1-benzazepin- 5-yl]-<i>N</i>-isopropylacetamide

Kazumi Kondo, Keizo Kan, Yoshihisa Tanada et al. · Journal of Medicinal Chemistry · 2002 · 45 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Pharmaceutical Chemistry +17

A short step synthesis of optically active myo-inositol 1,3,4,5-tetraki(phosphate) and myo-inositol 1,4,5-tris(phosphate) from 1,3,5-tri-O-benzoyl-myo-inositol

Yutaka Watanabe, Takahiro Fujimoto, Tomoichi Shinohara et al. · Journal of the Chemical Society Chemical Communications · 1991 · 31 citations

Practial Synthesis, Diversity Oriented Synthesis, Biosynthesis +13

Pinacol rearrangement for constructing asymmetric centers adjacent to heterocycles

Tomoichi Shinohara, Keisuke Suzuki · Tetrahedron Letters · 2002 · 31 citations

Pattern Formation, Pinacol Rearrangement, Heterocyclic +4

Characterization of a novel nonpeptide vasopressin V₂‐agonist, OPC‐51803, in cells transfected human vasopressin receptor subtypes

Shigeki Nakamura, Yoshitaka Yamamura, S. Itoh et al. · British Journal of Pharmacology · 2000 · 30 citations · Full text

Immunology, Human Avp V, Pharmacotherapy +19